Biotech

All Articles

Sanofi's $80M bank on Fulcrum dystrophy medication finishes in phase 3 go belly up

.Merely four months after Sanofi wager $80 million in upfront cash on Pivot Rehabs' losmapimod, the ...

Oncternal equity drains 60% amidst unemployments, trial discontinuations

.Cancer cells firm Oncternal Therapeutics is actually folding all its clinical tests and laying off ...

Roche is actually holding out hopes that its own injectable excessive weight prospect could inevitably display 25% fat loss in late-stage trial

.Roche is actually keeping out chances that its injectable excessive weight prospect can ultimately ...

Novo Nordisk hails 'outstanding' fat loss result for dual-acting dental medication in very early trial

.Novo Nordisk has lifted the top on a phase 1 trial of its dental amylin and GLP-1 receptor co-agoni...

AbbVie files a claim against BeiGene over blood stream cancer cells medicine trade secrets

.Merely a couple of quick weeks after gaining an FDA Fast lane tag for its investigational BTK degra...

Lilly delivers one-two blow along with second tranche of favorable records on every week blood insulin prospect

.Soon after a good data decline for Eli Lilly's efsitora alfa, the Indianapolis-based firm is actual...

BridgeBio cuts genetics therapy finances as professional data let down

.BridgeBio Pharma is actually lowering its own gene treatment spending plan and also pulling back co...

GSK submits HSV vaccination wishes after period 2 fall short, transferring nationality to Moderna, BioNTech

.GSK's try to build the first injection for genital herpes simplex infection (HSV) has ended in fail...

GSK's long-acting breathing problem drug cut in half strikes in phase 3

.GSK's long-acting breathing problem therapy has actually been actually presented to cut in half the...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival stop working

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually sto...